Showing results (51-60 of 290) with videos related to
Sort By:
Pageof 29
Expert Opinion on Biological Therapy|October 20, 2010
Canakinumab for treatment of cryopyrin-associated periodic syndromeEugen Feist, Gerd R BurmesterThe Lancet. Rheumatology|January 17, 2024
Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trialJens Y Humrich, Caroline von Spee-Mayer, Elise Siegert, et al.Deutsches Arzteblatt International|June 15, 2017
The Diagnosis and Treatment of Sjögren's SyndromeAna-Luisa Stefanski, Christian Tomiak, Uwe Pleyer, et al.BMC Rheumatology|December 28, 2021
Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2Frédéric Muench, Martin Krusche, Leif Erik Sander, et al.Journal of Clinical Medicine|May 28, 2022
Curcumin: Useful add-on for Rheumatic Diseases?Stylianos Tomaras, Gernot Keyßer, Eugen FeistDeutsche Medizinische Wochenschrift (1946)|July 3, 2020
[Idiopathic Inflammatory Myopathies]Stylianos Tomaras, Jörn Kekow, Eugen FeistNature Reviews. Rheumatology|September 16, 2018
Mechanisms, biomarkers and targets for adult-onset Still's diseaseEugen Feist, Stéphane Mitrovic, Bruno FautrelSeminars in Arthritis and Rheumatism|August 1, 2017
Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)Guido Junge, June Mason, Eugen FeistArthritis Research & Therapy|March 16, 2018
Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activityChristian Schwedler, Thomas Häupl, Ulrich Kalus, et al.Pharmaceuticals (Basel, Switzerland)|October 27, 2022
SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential DiagnosisJakob Höppner, Vincent Casteleyn, Robert Biesen, et al.Pageof 29